Q1. Proportion of patients receiving tranexamic acid within 1 h of protocol activation |
X |
X |
Q2. Proportion of patients in whom RBC transfusion is initiated within 15 min of protocol activation |
X |
X |
Q3. Proportion of patients (of patients requiring transfer for definitive care) with initiation of call for transfer within 60 min of protocol activation |
X |
|
Q4. Proportion of patients achieving temperature ≥ 35°C at termination of the protocol |
X |
|
Q5. Proportion of patients with hemoglobin levels maintained between 60 and 110 g/L during protocol activation, excluding certain pediatric populations (e.g., neonates) that may require higher hemoglobin values |
X |
|
Q6. Proportion of patients transitioned to group-specific red blood cells and plasma within 90 min of arrival/onset of hemorrhage |
X |
X |
Q7. Proportion of patients with appropriate activation (≥ 6 RBC units in first 24 h, > 40 mL/kg per 24 h of RBCs in pediatric patients) or before this level in patients dying due to hemorrhage within 24 h |
X |
|
Q8. Proportion of patients without any blood component wastage (including plasma that is thawed and not used within the 5-day limit on another patient) |
X |
|